checkAd

     662  0 Kommentare Hansen Medical(R) Announces Successful Enrollment of Initial Cohort in Artisan(R) U.S. Clinical Trial - Seite 2

    Cardiac arrhythmias are abnormal electrical signals in the heart. Atrial fibrillation is the most common form of cardiac arrhythmia, affecting nearly 3 million people in the United States alone. In radiofrequency catheter ablation, a catheter is inserted into the left atrium and radiofrequency energy is delivered to the heart tissue to create scars, which are intended to block erratic electrical impulses so the left atrium can beat normally.

    About the Sensei® Robotic System
    The Sensei Robotic System combines advanced levels of 3D catheter control and 3D visualization. This unique, state of the art technology has been used in over 17,000 patients, and is powered by a robotically controlled arm that allows for catheter navigation, stability and positioning within the patient's heart atria. The Sensei Robotic System, control catheters and accessories are intended to facilitate manipulation, positioning and control of Hansen Medical's robotically steerable catheters for collecting electrophysiological data within the heart atria with electro-anatomic mapping and recording systems, using specified percutaneous mapping catheters. The Sensei Robotic System is powered by a robotically controlled arm that allows for catheter navigation and stability. The safety and effectiveness of this device for use with cardiac ablation catheters, in the treatment of cardiac arrhythmias including atrial fibrillation, have not been established.

    About Hansen Medical, Inc.
    Hansen Medical, Inc., based in Mountain View, California, is a global leader in Intravascular Robotics, developing products and technology designed to enable the accurate positioning, manipulation and control of catheters and catheter-based technologies. The Company's Magellan™ Robotic System, Magellan Robotic Catheters, and related accessories are intended to facilitate navigation to anatomical targets in the peripheral vasculature and subsequently provide a conduit for manual placement of therapeutic devices. The Company's mission is to enable Cardiac Arrhythmia and Endovascular Procedures and to improve patient outcomes through the use of Intravascular Robotics. Additional information can be found at www.hansenmedical.com.

    Seite 2 von 4






    Verfasst von Marketwired
    Hansen Medical(R) Announces Successful Enrollment of Initial Cohort in Artisan(R) U.S. Clinical Trial - Seite 2 MOUNTAIN VIEW, CA--(Marketwired - Jul 6, 2015) -  Hansen Medical®, Inc. (NASDAQ: HNSN), the global leader in intravascular robotics, today announced it has completed enrollment in the initial evaluable cohort of the ARTISAN® clinical trial. …

    Schreibe Deinen Kommentar

    Disclaimer